The ET(A)-receptor antagonist LU 135252 prevents the progression of established pulmonary hypertension induced by monocrotaline in rats

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 4, Issue 1, 1999, Pages 33-39

  Dupuis, J ^a   Prie, S ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Endothelial function; Endothelial receptors; Endothelins; Nitric oxide; Pulmonary circulation

Indexed keywords

DARUSENTAN; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; MONOCROTALINE; N(G) NITROARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG ANTAGONISM; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; ISOLATED LUNG; LUNG BLOOD VESSEL; LUNG CIRCULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SURVIVAL RATE;

EID: 0033027294     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424849900400106     Document Type: Article

References (27)